SWIFT* k+ reduction AFTER ONE HOUR1,2

Sustained k+ control FOR UP TO ONE YEAR

WHEN USED AS MAINTENANCE THERAPY**1

Now in your hands.

New, highly-selective LOKELMATM (sodium zirconium cyclosilicate) is indicated for the treatment of hyperkalaemia in adult patients1

*In an emergency situation, standard of care should be used in line with local or national guidelines

** Clinical trials with LOKELMA have not included exposure longer than one year.

GB-17626 June 2019

Get Started